Switzerland· 65091001
Incruse Ellipta
A umeclidinium bromide product containing umeclidinium, registered in Switzerland and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 12 of our 19 countries.
Checked against BAG Spezialitätenliste (Switzerland) on
Informational only — not a medical device.
Where it is registered
Umeclidinium bromide is registered in 12 of 19 countries.
Countries holding a registration under ATC R03BB07 (umeclidinium bromide), each read from that country’s own register.
- This record: Switzerland, from BAG Spezialitätenliste (Switzerland)
- 7 of them publish a price we can compare per daily dose
Umeclidinium bromide · ATC R03BB07
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
Price per daily dose
What a daily dose of umeclidinium bromide costs, country by country.
Normalised to the WHO defined daily dose (55 mcg), so markets compare like for like.
- Switzerland: $1.57 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Umeclidinium bromide · price per daily dose (55 mcg)
USD · FX 28 Sept 2026
- CH Switzerland$1.57
The record
At a glance
BAG Spezialitätenliste (Switzerland)- Active substance
- umeclidinium
- Manufacturer
- —
- Country
- Switzerland (CH)
- ATC code
- R03BB07
- ATC class
- Umeclidinium bromide
- Defined daily dose
- 55 mcg, Inhal
- Swissmedic category
- B
- Reimbursed
- Yes
- Source register
- BAG Spezialitätenliste (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- gtin768065091001530 DosCHF 50.25
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
114 interactions on record for umeclidinium bromide.
Graded by severity as the source publishes them — 113 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Umeclidinium bromide · interactions on record
114 records
- 113 moderate
- 1 minor
Most severe, free to view
- DicycloverineA03AA07moderate
- PropanthelineA03AB05moderate
- MepenzolateA03AB12moderate
- TrospiumA03AB20moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Umeclidinium bromide in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaINCRUSE ELLIPTAGlaxoSmithKline Trading Services Limited, Dublin
- SpainINCRUSE ELLIPTA 55 mcg POLVO PARA INHALACION UNIDOSISGlaxosmithkline Trading Services Limited
- BelgiumIncruse Ellipta 55 µgGlaxoSmithKline Trading Services
- FinlandIncruse ElliptaParanova Oy
- SwedenIncruse Ellipta 55 mikrogram Inhalationspulver, avdelad dosGlaxoSmithKline Trading Services Ltd
- IrelandIncruse Ellipta 55 micrograms inhalation powder, pre-dispensedGlaxoSmithKline Trading Services Limited
- NetherlandsIncruse Ellipta 55 microgram inhalatiepoeder, voorverdeeldGlaxoSmithKline Trading Services Limited
- PolandIncruse ElliptaGlaxoSmithKline (Ireland) Limited
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Incruse Ellipta, Rolufta Ellipta
- Liechtenstein · Incruse Ellipta, Rolufta Ellipta
- Norway · Incruse Ellipta, Rolufta Ellipta
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of BAG Spezialitätenliste (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/dcf3b82e-7c29-41bb-9cfe-f0e7d0eece11 GET /v1/drugs/dcf3b82e-7c29-41bb-9cfe-f0e7d0eece11?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unit": null,
"strength": "umeclidinium 55 mcg",
"valid_from": "2015-09-01",
"limitations": null,
"galenic_form": "Inh Plv 55 mcg",
"therapeutic_area": null,
"sl_inclusion_date": "2015-09-01",
"self_retention_pct": 10
}See everything about umeclidinium bromide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.